Mélanie Tichet

1.7k total citations
20 papers, 1.1k citations indexed

About

Mélanie Tichet is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Mélanie Tichet has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 10 papers in Molecular Biology and 9 papers in Immunology. Recurrent topics in Mélanie Tichet's work include Cancer Immunotherapy and Biomarkers (5 papers), Bone and Dental Protein Studies (4 papers) and Immunotherapy and Immune Responses (4 papers). Mélanie Tichet is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Bone and Dental Protein Studies (4 papers) and Immunotherapy and Immune Responses (4 papers). Mélanie Tichet collaborates with scholars based in France, Switzerland and United States. Mélanie Tichet's co-authors include Sophie Tartare‐Deckert, Stéphane Rocchi, Marcel Deckert, Robert Ballotti, Douglas Hanahan, Nina Fenouille, Mickaël Ohanna, Aude Mallavialle, J.‐P. Lacour and Damien Giacchero and has published in prestigious journals such as Science, Nature Communications and Blood.

In The Last Decade

Mélanie Tichet

19 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mélanie Tichet France 16 674 441 303 196 103 20 1.1k
Jean‐Philippe Brosseau Canada 14 604 0.9× 304 0.7× 248 0.8× 200 1.0× 95 0.9× 24 1.2k
Victoria Hill United States 17 729 1.1× 338 0.8× 185 0.6× 220 1.1× 158 1.5× 23 1.2k
Noam Cohen Israel 12 636 0.9× 672 1.5× 484 1.6× 267 1.4× 58 0.6× 24 1.3k
Fotis Asimakopoulos United States 20 538 0.8× 557 1.3× 333 1.1× 194 1.0× 160 1.6× 40 1.3k
Marianna B. Ruzinova United States 15 822 1.2× 504 1.1× 225 0.7× 286 1.5× 77 0.7× 36 1.4k
Jennifer Cain United States 11 671 1.0× 470 1.1× 181 0.6× 149 0.8× 47 0.5× 19 1.1k
Aude Mallavialle France 15 409 0.6× 337 0.8× 184 0.6× 161 0.8× 104 1.0× 23 791
Min Soon Cho United States 17 845 1.3× 776 1.8× 356 1.2× 389 2.0× 61 0.6× 31 1.6k
Magdalena Karbowniczek United States 20 922 1.4× 530 1.2× 437 1.4× 179 0.9× 95 0.9× 30 1.8k
Myriam Labelle United States 13 574 0.9× 631 1.4× 194 0.6× 235 1.2× 143 1.4× 19 1.3k

Countries citing papers authored by Mélanie Tichet

Since Specialization
Citations

This map shows the geographic impact of Mélanie Tichet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mélanie Tichet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mélanie Tichet more than expected).

Fields of papers citing papers by Mélanie Tichet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mélanie Tichet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mélanie Tichet. The network helps show where Mélanie Tichet may publish in the future.

Co-authorship network of co-authors of Mélanie Tichet

This figure shows the co-authorship network connecting the top 25 collaborators of Mélanie Tichet. A scholar is included among the top collaborators of Mélanie Tichet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mélanie Tichet. Mélanie Tichet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bakiri, Latifa, Mélanie Tichet, Carolina Marques, et al.. (2025). A new effLuc/Kate dual reporter allele for tumor imaging in mice. Disease Models & Mechanisms. 18(1).
2.
Tichet, Mélanie, Stephan Wullschleger, Agnieszka Chryplewicz, et al.. (2023). Bispecific PD1-IL2v and anti-PD-L1 break tumor immunity resistance by enhancing stem-like tumor-reactive CD8+ T cells and reprogramming macrophages. Immunity. 56(1). 162–179.e6. 80 indexed citations
3.
Chryplewicz, Agnieszka, Mélanie Tichet, Anoek Zomer, et al.. (2022). Cancer cell autophagy, reprogrammed macrophages, and remodeled vasculature in glioblastoma triggers tumor immunity. Cancer Cell. 40(10). 1111–1127.e9. 82 indexed citations
4.
Zeng, Qiqun, Sadegh Saghafinia, Agnieszka Chryplewicz, et al.. (2022). Aberrant hyperexpression of the RNA binding protein FMRP in tumors mediates immune evasion. Science. 378(6621). eabl7207–eabl7207. 62 indexed citations
5.
Wullschleger, Stephan, Mélanie Tichet, Laura Codarri Deak, et al.. (2021). Abstract 71: The immunocytokine PD1-IL2v overcomes immune checkpoint resistance, and combination with an anti-PD-L1 antibody further enhances its anti-tumor activity. Cancer Research. 81(13_Supplement). 71–71. 1 indexed citations
6.
Wullschleger, Stephan, Mélanie Tichet, Dhaarini Murugan, et al.. (2019). Myeloid Cells Orchestrate Systemic Immunosuppression, Impairing the Efficacy of Immunotherapy against HPV+ Cancers. Cancer Immunology Research. 8(1). 131–145. 28 indexed citations
7.
Rathore, Moeez, Christophe A. Girard, Mickaël Ohanna, et al.. (2019). Cancer cell-derived long pentraxin 3 (PTX3) promotes melanoma migration through a toll-like receptor 4 (TLR4)/NF-κB signaling pathway. Oncogene. 38(30). 5873–5889. 64 indexed citations
8.
Michael, Iacovos P., Sadegh Saghafinia, Mélanie Tichet, et al.. (2019). ALK7 Signaling Manifests a Homeostatic Tissue Barrier That Is Abrogated during Tumorigenesis and Metastasis. Developmental Cell. 49(3). 409–424.e6. 30 indexed citations
9.
Mallavialle, Aude, Mélanie Tichet, Patrick Auberger, et al.. (2018). Targeting the Proteasome-Associated Deubiquitinating Enzyme USP14 Impairs Melanoma Cell Survival and Overcomes Resistance to MAPK-Targeting Therapies. Molecular Cancer Therapeutics. 17(7). 1416–1429. 44 indexed citations
10.
Tichet, Mélanie, Sonia Domingos‐Pereira, Sylvie Hauert, et al.. (2018). Nanoparticle Conjugation of Human Papillomavirus 16 E7-long Peptides Enhances Therapeutic Vaccine Efficacy against Solid Tumors in Mice. Cancer Immunology Research. 6(11). 1301–1313. 30 indexed citations
11.
Campos, Vasco, et al.. (2018). Cellular endogenous NAD(P)H fluorescence as a label‐free method for the identification of erythrocytes and reticulocytes. Cytometry Part A. 93(4). 472–479. 2 indexed citations
12.
Crottès, David, Raphaël Rapetti‐Mauss, Francisca Alcaraz‐Pérez, et al.. (2015). SIGMAR1 Regulates Membrane Electrical Activity in Response to Extracellular Matrix Stimulation to Drive Cancer Cell Invasiveness. Cancer Research. 76(3). 607–618. 53 indexed citations
13.
Tichet, Mélanie, Virginie Prod’homme, Nina Fenouille, et al.. (2015). Tumour-derived SPARC drives vascular permeability and extravasation through endothelial VCAM1 signalling to promote metastasis. Nature Communications. 6(1). 6993–6993. 157 indexed citations
14.
Tichet, Mélanie, et al.. (2014). Risk for Nevus Transformation and Melanoma Proliferation and Invasion During Natalizumab Treatment. JAMA Dermatology. 150(8). 901–901. 11 indexed citations
15.
Cerezo, Michaël, Mélanie Tichet, Patricia Abbe, et al.. (2013). Metformin Blocks Melanoma Invasion and Metastasis Development in AMPK/p53-Dependent Manner. Molecular Cancer Therapeutics. 12(8). 1605–1615. 174 indexed citations
16.
Fenouille, Nina, Mélanie Tichet, Maeva Dufies, et al.. (2012). The Epithelial-Mesenchymal Transition (EMT) Regulatory Factor SLUG (SNAI2) Is a Downstream Target of SPARC and AKT in Promoting Melanoma Cell Invasion. PLoS ONE. 7(7). e40378–e40378. 167 indexed citations
17.
Puissant, Alexandre, Maeva Dufies, Nina Fenouille, et al.. (2012). Imatinib triggers mesenchymal-like conversion of CML cells associated with increased aggressiveness. Journal of Molecular Cell Biology. 4(4). 207–220. 32 indexed citations
18.
Fenouille, Nina, Alexandre Puissant, Mélanie Tichet, et al.. (2011). SPARC functions as an anti-stress factor by inactivating p53 through Akt-mediated MDM2 phosphorylation to promote melanoma cell survival. Oncogene. 30(49). 4887–4900. 53 indexed citations
19.
Fenouille, Nina, Guillaume Robert, Mélanie Tichet, et al.. (2010). The p53/p21Cip1/ Waf1 pathway mediates the effects of SPARC on melanoma cell cycle progression. Pigment Cell & Melanoma Research. 24(1). 219–232. 36 indexed citations
20.
Meynet, Ophélie, Mélanie Tichet, Katia Scotlandi, et al.. (2008). Regulation of HLA class I surface expression requires CD99 and p230/golgin-245 interaction. Blood. 113(2). 347–357. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐Philippe Brosseau Breakdown of academic impact, for papers by Victoria Hill Breakdown of academic impact, for papers by Noam Cohen Breakdown of academic impact, for papers by Fotis Asimakopoulos Breakdown of academic impact, for papers by Marianna B. Ruzinova Breakdown of academic impact, for papers by Jennifer Cain Breakdown of academic impact, for papers by Aude Mallavialle Breakdown of academic impact, for papers by Min Soon Cho Breakdown of academic impact, for papers by Magdalena Karbowniczek Breakdown of academic impact, for papers by Myriam Labelle
Rankless by CCL
2026